🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7157495

Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benz

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7150984

Attenuated human rotavirus vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7148323

Major neutralization site of hepatitis E virus and use of this neutralization site in meth

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7141405

Chimeric GB virus B (GBV-B)

The Board of Regents of the University of Texas System · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7135324

Viral recombinases, related articles, and methods of use thereof

UNIVERSITY OF CONNECTICUT · Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7132271

Methods for enhancing the production of viral vaccines in cell culture

The Regents of the University of California · Granted Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7129342

Infectious cDNA clone of GB virus B and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7118738

Recombinant pox virus for immunization against MUC1 tumor-associated antigen

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7115590

Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin

University College Cardiff Consultants Limited · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105156

Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproli

The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105169

Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7101541

Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7094411

Avirulent, immunogenic flavivirus chimeras

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7094408

Immunogenicity using a combination of DNA and vaccinia virus vector vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7094598

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7094406

Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes ther

The United States of America as represented by the Secretary of the Department of Health and Human Services and Genelabs Technologies, Inc. · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7090852

Venezuelan equine encephalitis virus replicon encoding marburg virus proteins

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 15 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7087234

Recombinant multivalent viral vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7084266

Cloned genome of infectious hepatitus C virus of genotype 2A and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7070790

Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates o

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7052904

Hybrid adeno-retroviral vector for the transfection of cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7052696

Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7049127

Method of producing infectious reovirus

ONCOLYTICS BIOTECH INC. · Granted Tue May 23 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7048935

Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 23 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired